The Company was established in 2013 by Dr Michael Åkesson to pursue his invention improving the procedure of minimally invasive treatment in the condition of varicose vein. With the plan to capitalise on a medical device, and after extensive research and development work the company filed for a patent in 2015 which was granted and published in 2017.
The vision leading all company efforts now is to launch a market-winning product which will improve patients’ well-being, shorten the treatment procedure and provide security to doctors. MedVASC AB aims to make Solutio the standard for administering anaesthesia in varicose vein treatment. The company’s mission is to provide the most efficient and the safest treatment with minimum pain and maximum comfort to the patient.